Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selfie: Autoimmunity, boon or bane.

Haseeb Ahsan1

  • 1a Department of Biochemistry , Jamia Millia Islamia , New Delhi , India.

Journal of Immunoassay & Immunochemistry
|April 20, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: Pharmacological support to anti-arthritic prospective of physostigmine: a new approach.

Inflammopharmacology·2025
Same author

Gastrocnemius Myofiber Type and Mitochondrial Alterations Associated With Peripheral Artery Disease Severity.

Function (Oxford, England)·2025
Same author

Matrix metalloproteinases are hallmark early biomarkers and therapeutic targets in FSHD.

JCI insight·2025
Same author

Retraction Note: Anti-rheumatic activity of pseudoephedrine (a substituted phenethylamine) in complete Freund's adjuvant-induced arthritic rats by down regulating IL-1β, IL-6 and TNF-α as well as upregulating IL-4 and IL-10.

Inflammopharmacology·2025
Same author

Pharmacological targeting of P300/CBP reveals EWS::FLI1-mediated senescence evasion in Ewing sarcoma.

Molecular cancer·2024
Same author

<i>Trans</i>-Chalcone (1-3-diphenyl-2-propen-1-one) as a Therapeutic Candidate in Joint Inflammation via Reduction of TNF-α, IL-1β, IL-6, and IL-17 in Rodents: An <i>In Vivo</i> Study by RT-PCR and ELISA analysis.

ACS omega·2024

Autoimmune diseases involve immune system self-attack, driven by genetic and environmental factors. Autoantibodies and inflammation are key features in conditions like systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).

Area of Science:

  • Immunology
  • Pathophysiology
  • Autoimmunity

Background:

  • The immune system defends against pathogens but can mistakenly attack self-tissues in autoimmune diseases.
  • Autoimmune diseases stem from genetic predispositions and environmental triggers.
  • Key hallmarks include autoantibodies and inflammation involving various immune cells.

Purpose of the Study:

  • To elucidate the role of B cells and autoantibodies in autoimmune disease pathogenesis.
  • To differentiate between organ-specific and non-organ specific autoimmune conditions.
  • To highlight the specific mechanisms in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).

Main Methods:

  • Review of immunological mechanisms in autoimmunity.
  • Classification of autoimmune diseases based on target antigens.
Keywords:
Autoimmunityautoantibodiesautoantigensrheumatoid arthritissystemic lupus erythematosus

Related Experiment Videos

  • Analysis of key cellular and molecular players in SLE and RA.

    • Main Results:

    • B cells producing autoantibodies are central to autoimmune disease development.
    • Autoimmune diseases are categorized as organ-specific or non-organ specific.
    • Systemic lupus erythematosus (SLE) involves circulating autoantibodies and immune complex deposition.
    • Rheumatoid arthritis (RA) pathogenesis is driven by T cells, B cells, and pro-inflammatory cytokines.

    Conclusions:

    • Autoantibodies and inflammation are critical components of autoimmune diseases.
    • Understanding specific disease pathways, like those in SLE and RA, is crucial for targeted therapies.
    • B cell activity significantly contributes to the self-destructive nature of autoimmunity.